Showing 2,261 - 2,280 results of 133,910 for search '(( 2 we decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.76s Refine Results
  1. 2261
  2. 2262
  3. 2263
  4. 2264
  5. 2265
  6. 2266
  7. 2267
  8. 2268
  9. 2269
  10. 2270

    Image_2_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF by Hilde L. Orrem (5740313)

    Published 2018
    “…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
  11. 2271
  12. 2272

    Table 2_Fatal HLH in patients with X-linked lymphoproliferative disease 1 due to a novel variant in SH2D1A: case report.docx by Oksana Boyarchuk (8910488)

    Published 2025
    “…</p>Conclusion<p>We identified a novel SH2D1A variant associated with fatal HLH in XLP1. …”
  13. 2273

    Table 1_Fatal HLH in patients with X-linked lymphoproliferative disease 1 due to a novel variant in SH2D1A: case report.docx by Oksana Boyarchuk (8910488)

    Published 2025
    “…</p>Conclusion<p>We identified a novel SH2D1A variant associated with fatal HLH in XLP1. …”
  14. 2274

    Table 3_Fatal HLH in patients with X-linked lymphoproliferative disease 1 due to a novel variant in SH2D1A: case report.docx by Oksana Boyarchuk (8910488)

    Published 2025
    “…</p>Conclusion<p>We identified a novel SH2D1A variant associated with fatal HLH in XLP1. …”
  15. 2275

    We simulated a spatially homogeneous version of the Model. by Matteo Semplice (181197)

    Published 2012
    “…<p>We mimick the experimental conditions by switching on receptor activation at initial time. …”
  16. 2276
  17. 2277
  18. 2278
  19. 2279
  20. 2280